Skip to main content
NIVFW logo

NewGenIvf Group Limited (NIVFW) Stock Price & Analysis

NewGenIvf Group Limited (NIVFW) — price $0.0066 (0.00%), as of the Nov 19, 2026 trading session.

Educational signal · not a buy or sell recommendation · How to read this

$0.0066 $0.00 (0.00%)

NewGenIvf Group Limited · NIVFW

NewGenIvf Group Limited is an investment holding company providing assisted reproductive services in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. Their services include in vitro fertilization (IVF) and related treatments through their network of clinics.

Price as of Nov 19, 2026

Key Statistics

Not scored: this is a debt/preferred or other non-common instrument, or its reported market value does not match its share basis.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

Scored companies in the same industry:

  • BFRG · Bullfrog AI Holdings, Inc. Common Stock · 20 /100
  • HCA · HCA Healthcare, Inc. · 77 /100
  • THC · Tenet Healthcare Corporation · 94 /100

See all scored stocks →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$0.0066
Change on the day0.00%
52-week range$0.0051 – $0.09
Price / earnings (trailing)0.00
Shares traded on the day3.0K

Price & events

Other perspectives

Council score for NewGenIvf Group (NIVFW): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Legends Council

6 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Unfavorable read
Simons-style lens (simulated) Jim Simons Favorable read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Favorable read

Read on: Sep 5, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Neutral
Margin of Safety Undervalued
Profit Margin Strong
Revenue Growth Negative
Debt/Equity Moderate
ROE Strong
Gross Margin Weak

Read on: May 23, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On May 23, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is NewGenIvf Group (NIVFW), and what does it report?

Short answer · as of

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. NewGenIvf Group Limited (NIVFW) is the company analyzed here. It employs 87 people and is led by Wing Fung Siu. In Q2 FY2026 it reported revenue of $1.92B and net income of -$8.04B.

2 · Latest results

What do the latest results show for NewGenIvf Group (NIVFW)?

Short answer · as of

The most recent reported quarter, Q2 FY2026, carried revenue of $1.92B.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q2 FY2026$1.92B-$8.04B-$491756.79 (diluted)
Q4 FY2025$1M-$8M-$469.33 (diluted)
Q3 FY2025$1M$17M$1029.60 (diluted)
Q4 FY2024$1M-$108,000-$6.61 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for NewGenIvf Group (NIVFW)?

Short answer · as of

The distress and quality screens read Altman Z 1.07 · Piotroski F 6. Trailing ratios: current ratio 1.06.

The records behind this page

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Oct 5, 2026

Transactions
19
Identified insiders
4
Purchases
7
Sales
2
Other transactions
10

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held NIVFW in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported NIVFW in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

Investor Questions: NIVFW Stock

These answers are editorial: 1 of these 1 answer is drawn from the NIVFW research dossier (written Mar 18, 2026 by gemini-2.0-flash). Figures in this section are not part of the source register.

What are the key growth opportunities for NIVFW in healthcare?

NewGenIvf Group Limited has several growth opportunities within the healthcare sector. Expanding its geographic footprint into new markets, such as Vietnam or Indonesia, can significantly increase its patient base.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 14 figures on this page — 9 from Financial Modeling Prep (FMP) and 5 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.